The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302

Diabetes

Volumn 46, Issue 11, 1997, Pages 1888-1892

  Nejentsev, Sergei ^a,b   Reijonen, Helena ^a   Adojaan, Bela ^c   Kovalchuk, Liliya ^d   Sochnevs, Arthur ^d   Schwartz, Eugene I ^b   Åkerblom, Hans K ^e   Ilonen, Jorma ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d RIGA STRADINS UNIVERSITY   (Latvia)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; BALTIC STATES; CHILD; CONTROLLED STUDY; ESTONIA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATVIA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; RUSSIAN FEDERATION;

EID: 0030701914     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1888     Document Type: Article

References (25)

1. Wassmuth R, Lernmark Å: The genetics of susceptibility to diabetes. Clin Immunol Immunopathol 53:358-399, 1989
2. Todd JA; Genetic analysis of type 1 diabetes using whole genome approaches. Proc Nat Acad Sci USA 92:8560-8565, 1995
3. Thorsby E, Rønningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type-1 (insulin-dependent) diabetes-mellitus. Diabetologia 36:371-377, 1993
4. Ilonen J, Reijonen H: Special genetic features of the populations in Nordic countries as related to risk of IDDM. Diabetes in the Young 29:10-16, 1993
5. She J-X: Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 17:323-329, 1996
6. Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T: Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870-877, 1995
7. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225-235, 1992
8. Baur MP, Neugebauer M, Albert E: Reference tables of two-locus haplotype frequencies for all MHC marker loci. In Histocompatibility Testing 1984. Albert ED, Baur MP, Mayr WR, Eds. Berlin, Heidelberg, Germany, Springer-Verlag, 1984, p. 677-755
9. Mustonen A, Ilonen J, Surcel H-M, Åkerblom HK: A "new" DR4 associated D specificity "JA" in type 1 (insulin-dependent) diabetes: A9,Bw16,DJA,DR4 haplotype. Diabetologia 27:126-128, 1984
10. Tienari PJ, Tuomilehto-Wolf E, Tuomilehto J, Peltonen L: HLA haplotypes in type-1 (insulin-dependent) diabetes-mellitus: molecular analysis of the HLA-DQ locus. Diabetologia 35:254-260, 1992
11. Bunce M, Fanning GC, Welsh KI: Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 45:81-90, 1995
12. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F: Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 181:1847-1855, 1995
13. Karvonen M, Tuomilehto J, Libman I, Laporte R: A review of the recent epidemiological data on the worldwide incidence of type-1 (insulin-dependent) diabetes-mellitus. Diabetologia 36:883-892, 1993
14. Undlien DE, Friede T, Rammensee H-G, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen HE, Knutsen I, Rønningen KS, Thorsby E: HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 46:143-149, 1997
15. Sanjeevi CB, Hook P, Landin-Olsson M, Kockum I, Dahlquist G, Lybrand TP, Lernmark Å: DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes. Tissue Antigens 47:275-283, 1996
16. Tuokko J, Reijonen H, Ilonen J, Anttila K, Nikkari S, Möttönen T, Yli-Kerttula U, Toivanen A: Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis. Ann Rheum Dis 56:37-40, 1997
17. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilalisaiah I, Bougneres P, Bach JF: Age-dependent HLA genetic heterogeneity of type-1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
18. VanderAuwera B, VanWaeyenberge C, Schuit F, Heimberg H, Vandewalle C, Gorus F, Flament J, Belgian Diabetes Registry: DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes 44:527-530, 1995
19. Retjonen H, Nejentsev S, Tuokko J, Koskinen S, Tuomilehto-Wolf E, Åkerblom HK, Ilonen J, the Childhood Diabetes in Finland Study Group: HLA-DR4 subtype and -B alleles in DQB1*0302 positive haplotypes associated with IDDM. Eur J Immunogen. In press
20. Ilonen J, Åkerblom HK, Tiilikainen A, Mustonen A, Herva E, Koskimies S, Kouvalainen K; Increase of HLA haplotype A9-Bw16 in familial insulin-dependent diabetes mellitus in Northern Finland. Acta Diabetol 21:167-174, 1982
21. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD: Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med 1:576-582, 1995
22. Berkos AS, Bubnova LN, Beliaeva EV, Nikolenko VN, Erochina LV: The association of HLA-antigens with insulin-dependent diabetes mellitus (IDDM) in Saint-Petersburg (Russia) (Abstract). Hum Immunol 47:157, 1996
23. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class-n major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes-mellitus. Eur J Immunol 23:224-231, 1993
24. Demaine AG, Hibberd ML, Mangles D, Millward BA: A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia 38:623-628, 1995
25. Ikegami H, Makino S, Yamato E, Kawaguchi Y, Ueda H, Sakamoto T, Takekawa K, Ogihara T: Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J Clin Invest 96:1936-1942, 1995